--Andrew-
In comparison to $3.44 a year earlier, Novartis' diluted earnings per share for the three quarters was $2.5. Revenue decreased 1% from the prior year to $37.855 billion.
A net income of $1.575 billion was announced for the third quarter, a 43% decrease from the corresponding quarter in 2021. A year ago, diluted earnings per share were $1.23; this year, they were $0.73.
The business noted that Novartis "produced solid third-quarter earnings and strong operating performance since the beginning of the year."
The current year's sales growth forecast was kept at the 4-6% range anticipated in July.
source: bloomberg.com
A net income of $1.575 billion was announced for the third quarter, a 43% decrease from the corresponding quarter in 2021. A year ago, diluted earnings per share were $1.23; this year, they were $0.73.
The business noted that Novartis "produced solid third-quarter earnings and strong operating performance since the beginning of the year."
The current year's sales growth forecast was kept at the 4-6% range anticipated in July.
source: bloomberg.com
